Jessica L. Taylor, MD is an Assistant Professor of Medicine in General Internal Medicine at the Chobanian and Avedisian School of Medicine and Boston Medical Center and a board-certified Addiction Specialist. She attended Mount Sinai School of Medicine and completed internal medicine residency training at Beth Israel Deaconess Medical Center and Harvard Medical School, where she also served as a Chief Resident. Dr. Taylor’s clinical work focuses on the care of patients with substance use disorders, HIV, and viral hepatitis.
Her research interests include HIV prevention among people who inject drugs, HIV pre-exposure prophylaxis (PrEP) implementation, low-barrier substance use disorder treatment models, and overdose prevention. She is Co-Director of the Care Continuum Core for the Massachusetts site of the NIDA-funded Healing Communities Study, which aims to reduce fatal opioid overdose by 40%.
Dr. Taylor is the Medical Director of Faster Paths to Treatment, Boston Medical Center’s innovative, low-barrier substance use disorder bridge clinic and the Medical Director of the Transitional Care Clinic, a bridge clinic co-located with a low-threshold, transitional housing program for people experiencing homelessness. She directs HIV Prevention Programs at BMC. Her educational roles include directing the HIV Pathway for internal medicine residents and serving as core faculty in BUSM’s Addiction Medicine fellowship program.
- Faculty, Clinical Addiction Research and Education Unit, Medicine, Boston University Chobanian & Avedisian School of Medicine
- Mount Sinai School of Medicine, MD
- Duke University, BS
- Published on 7/18/2023
Rawlins-Pilgrim S, Wheelock A, Streed CG, Higham M, Krakower DS, Taylor JL. Survey assessment of HIV pre-exposure prophylaxis availability in student health services in New England colleges and universities. J Am Coll Health. 2023 Jul 18; 1-4. PMID: 37463515.
- Published on 4/14/2023
Taylor JL, Wakeman SE, Walley AY, Kehoe LG. Substance use disorder bridge clinics: models, evidence, and future directions. Addict Sci Clin Pract. 2023 Apr 14; 18(1):23. PMID: 37055851.
- Published on 4/5/2023
Martin AK, Perryman T, Bernstein JA, Taylor JL, Cruz R, Muroff J, Samet JH, Assoumou SA. Peer recovery coaching for comprehensive HIV, hepatitis C, and opioid use disorder management: The CHORUS pilot study. Drug Alcohol Depend Rep. 2023 Jun; 7:100156. PMID: 37113387.
- Published on 3/24/2023
Lescure TN, Stewart J, Sperring H, Ruiz-Mercado G, Taylor JL. Impact of COVID-19 on Sexually Transmitted Infection and HIV Screening at an Urban Safety-Net Hospital. AIDS Patient Care STDS. 2023 Mar 24. PMID: 36961407.
- Published on 3/24/2023
Lescure TN, Stewart J, Sperring H, Ruiz-Mercado G, Taylor JL. Impact of COVID-19 on Sexually Transmitted Infection and HIV Screening at an Urban Safety-Net Hospital. AIDS Patient Care STDS. 2023 Apr; 37(4):199-204. PMID: 36961407.
- Published on 1/25/2023
Peterkin AF, Jawa R, Menezes K, You J, Cabral H, Ruiz-Mercado G, Park TW, Kehoe J, Taylor JL, Weinstein ZM. Pre-Paid Phone Distribution: A Tool for Improving Healthcare Engagement for People with Substance Use Disorder. Subst Use Misuse. 2023; 58(4):585-589. PMID: 36695079.
- Published on 11/1/2022
Braun HM, Walter C, Farrell N, Biello KB, Taylor JL. HIV Exposure Prophylaxis Delivery in a Low-barrier Substance Use Disorder Bridge Clinic during a Local HIV Outbreak at the Onset of the COVID-19 Pandemic. J Addict Med. 2022 Nov-Dec 01; 16(6):678-683. PMID: 36383918.
- Published on 7/29/2022
Weisenthal K, Kimmel SD, Kehoe J, Larochelle MR, Walley AY, Taylor JL. Effect of police action on low-barrier substance use disorder service utilization. Harm Reduct J. 2022 Jul 29; 19(1):86. PMID: 35906660.
- Published on 7/1/2022
Streed CG, Morgan JR, Gai MJ, Larochelle MR, Paasche-Orlow MK, Taylor JL. Prevalence of HIV Preexposure Prophylaxis Prescribing Among Persons With Commercial Insurance and Likely Injection Drug Use. JAMA Netw Open. 2022 Jul 01; 5(7):e2221346. PMID: 35819784.
- Published on 5/14/2022
Taylor JL, Laks J, Christine PJ, Kehoe J, Evans J, Kim TW, Farrell NM, White CS, Weinstein ZM, Walley AY. Bridge clinic implementation of "72-hour rule" methadone for opioid withdrawal management: Impact on opioid treatment program linkage and retention in care. Drug Alcohol Depend. 2022 Jul 01; 236:109497. PMID: 35607834.
View 23 more publications: View full profile at BUMC